Test of smaller-incision stomach surgery for gastric cancer
Part of Cancer, Digestive system clinical trials.
This trial studies a stomach cancer surgery done with fewer/smaller incisions (laparoscopic with reduced ports). It may help people with certain early-to-mid stage stomach cancers by comparing whether this approach is safe and effective for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed stomach cancer (adenocarcinoma) based on a pathology test (biopsy/surgery sample).
- Your cancer stage is between T1 and T4 (tumor has grown into certain layers/areas, but not the most advanced spread described here).
- Your daily functioning is good—your doctor rates you as 0 or 1, meaning you’re able to do most activities.
- Your blood and organ tests are “adequate,” meaning your heart, liver, kidneys, and blood counts can handle treatment.
- Your cancer has not spread to distant organs (no distant metastasis).
- Your tumor is not very large and does not have certain high-risk growth patterns, and it has not invaded the esophagus more than 3 cm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new set of surgical tools can help remove the entire stomach using small incisions (laparoscopy). It is for people with stomach cancer that hasn't spread widely and who are healthy enough for surgery.
This trial is testing a newer, less invasive robotic surgery technique that uses just one small incision to remove stomach cancer. It may offer faster recovery and less pain compared to traditional surgery.
This trial compares a newer, less invasive robotic surgery with the standard laparoscopic approach for removing part of the stomach in people with early-stage gastric cancer. It aims to see if the robotic method offers better recovery or outcomes.
This study looks at a surgical technique (“dual-port laparoscopic distal gastrectomy”) for people with stomach adenocarcinoma at an early, specific stage. The goal is to remove the tumor with clean margins (called an “R0” result) and see how this approach works safely.
This trial compares two minimally invasive surgical approaches for early-stage stomach cancer affecting the upper portion. Researchers want to see if a newer single-port technique (using one small incision) works as well as traditional laparoscopic surgery (using multiple small incisions) and may cause less pain or faster recovery.
This trial compares two ways surgeons remove the entire stomach (total gastrectomy): laparoscopic (small keyhole cuts) versus open surgery (one larger cut). It’s testing which approach is safer and works better for people with certain stages of stomach cancer.
Hear when a new Laparoscopic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.